Eakins Richard reported option exercise involving 36,052 derivative units of Guardian Pharmacy Services, Inc. on Sep 27, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Senior Vice President, Sales
Senior Vice President, Sales
Filed Sep 28, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
—Shares × reported price
Shares traded
36,052Class B Common Stock
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Sep 27, 2026Option exercise
Filed
Sep 28, 2026, 4:59 PM ET1-day reporting delay
Accession
0001193125-26-405486Code M · Transaction 230503
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 27, 2026Option exercise36,052——Trade 230502
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

GRDN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
GRDN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago 0%1w ago 0%1d ago 0%
Returns since7d +14%30d +8.9%90d180d1y

Footnotes in full

F1: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.